Eagle Pharmaceuticals
EGRX
#10505
Rank
NZ$4.95 M
Marketcap
NZ$0.38
Share price
46.67%
Change (1 day)
-64.16%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: NZ$4.95 Million

As of December 2025 Eagle Pharmaceuticals has a market cap of NZ$4.95 Million. This makes Eagle Pharmaceuticals the world's 10505th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$4.95 M-60.82%
2024NZ$12.63 M-88.23%
2023NZ$0.10 B-82.08%
2022NZ$0.59 B-37.76%
2021NZ$0.96 B14.47%
2020NZ$0.84 B-30.83%
2019NZ$1.21 B45.49%
2018NZ$0.83 B-25.54%
2017NZ$1.12 B-36.68%
2016NZ$1.77 B-12.5%
2015NZ$2.02 B629.53%
2014NZ$0.27 B

End of Day market cap according to different sources

On Dec 19th, 2025 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
NZ$4.95 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$863.49 B 17,440,775.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$172.11 B 3,476,203.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
NZ$453.40 B 9,157,677.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
NZ$60.47 B 1,221,308.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
NZ$306.15 B 6,183,679.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.668 T 33,692,065.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$191.58 B 3,869,588.03%๐Ÿ‡บ๐Ÿ‡ธ USA